Concomitant Tumor and Autoantigen Vaccination Supports Renal Cell Carcinoma Rejection
Authors:
Open Access
- 15 July 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 185 (2) , 902-916
Abstract
Efficient tumor vaccination frequently requires adjuvant. Concomitant induction of an autoimmune response is discussed as a means to strengthen a weak tumor Ag-specific response. We asked whether the efficacy of dendritic cell (DC) vaccination with the renal cell carcinoma Ags MAGE-A9 (MAGE9) and G250 could be strengthened by covaccination with the renal cell carcinoma autoantigen GOLGA4. BALB/c mice were vaccinated with DC loaded with MHC class I-binding peptides of MAGE9 or G250 or tumor lysate, which sufficed for rejection of low-dose RENCA-MAGE9 and RENCA-G250 tumor grafts, but only retarded tumor growth at 200 times the tumor dose at which 100% of animals will develop a tumor. Instead, 75–100% of mice prevaccinated concomitantly with Salmonella typhimurium transformed with GOLGA4 cDNA in a eukaryotic expression vector rejected 200 times the tumor dose at which 100% of animals will develop tumor. In a therapeutic setting, the survival rate increased from 20–40% by covaccination with S. typhimurium-GOLGA4. Autoantigen covaccination significantly strengthened tumor Ag-specific CD4+ and CD8+ T cell expansion, particularly in peptide-loaded DC-vaccinated mice. Covaccination was accompanied by an increase in inflammatory cytokines, boosted IL-12 and IFN-γ expression, and promoted a high tumor Ag-specific CTL response. Concomitant autoantigen vaccination also supported CCR6, CXCR3, and CXCR4 upregulation and T cell recruitment into the tumor. It did not affect regulatory T cells, but slightly increased myeloid-derived suppressor cells. Thus, tumor cell eradication was efficiently strengthened by concomitant induction of an immune response against a tumor Ag and an autoantigen expressed by the tumor cell. Activation of autoantigen-specific Th cells strongly supports tumor-specific Th cells and thereby CTL activation.Keywords
This publication has 74 references indexed in Scilit:
- Bacterial Antigen Expression Is an Important Component in Inducing an Immune Response to Orally Administered Salmonella-Delivered DNA VaccinesPLOS ONE, 2009
- RETRACTED: Immunosuppressive networks in the tumour environment and their effect in dendritic cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- Role of autologous and allogeneic stem cell transplantation in myelomaLeukemia, 2009
- Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell CarcinomaJournal of Immunotherapy, 2008
- Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinomaClinical Immunology, 2007
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007
- Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine modelCancer Immunology, Immunotherapy, 2007
- Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patientsBlood, 2006
- Cell Motility: Golgi Signalling Shapes up to Ship outCurrent Biology, 2004
- Novel variant of p230 trans-Golgi network protein identified by serum from Sjögren's syndrome patientEuropean Journal of Cell Biology, 2000